Bibliographic Details
| Title: |
Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers. |
| Authors: |
Ramanathan RK; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. ramanathanrk@upmc.edu, Fakih M, Mani S, Deutsch M, Perez RP, Ritter MA, Eiseman JL, Ivy SP, Trump DL, Belani CP, Parise RA, Potter DM, Egorin MJ |
| Source: |
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2006 Apr; Vol. 57 (4), pp. 465-74. Date of Electronic Publication: 2005 Aug 25. |
| Publication Type: |
Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: |
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0344-5704 (Print) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
